TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
R N MainiM Feldmann

Abstract

The role of the immune response in rheumatoid arthritis (RA) is a subject of debate, although it is widely believed to be a T-cell-driven disease. Progress is being hindered by lack of convincing evidence of a defined specific antigen initiating or perpetuating the response. Clinical trials using monoclonal antibodies directed against T-cell surface molecules such as CD4. CD5, and CD7 have thus far not provided evidence of efficacy. The negative data may reflect inadequate dosing or could suggest that indiscriminate depletion of T cells is insufficient by itself as a therapeutic strategy. Blocking proinflammatory cytokines (e.g. TNF alpha, IL-1) or augmenting anti-inflammatory cytokines (e.g. IL-10) offers an alternative approach to therapy. Clinical trials using monoclonal anti-TNF alpha have been particularly successful in controlling inflammation and markedly reducing acute phase proteins and cellular ingress. However, because disease invariably relapses, repeated therapy is necessary. Preliminary experience suggests that this is possible. Anti-TNF therapy for RA has defined a molecular target and new approach for treating immuno-inflammatory disorders.

References

Sep 26, 1992·Lancet·J D IsaacsH Waldmann
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R O WilliamsR N Maini
May 1, 1992·British Journal of Rheumatology·F M BrennanM Feldmann
Jun 1, 1990·Arthritis and Rheumatism·G S Firestein, N J Zvaifler
May 1, 1995·The Journal of Experimental Medicine·J HammerF Sinigaglia
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·R O WilliamsR N Maini
May 1, 1994·The Journal of Experimental Medicine·P D KatsikisM Feldmann
Nov 1, 1995·Baillière's Clinical Rheumatology·M J Elliott, R N Maini
Jan 1, 1996·Annual Review of Immunology·M FeldmannR N Maini
Jan 1, 1997·Advances in Immunology·M FeldmannR N Maini

❮ Previous
Next ❯

Citations

May 20, 1998·Research in Immunology·M G von Herrath
Apr 20, 2006·Nature Reviews. Immunology·Jonathan C W Edwards, Geraldine Cambridge
Dec 9, 1998·Clinical and Experimental Immunology·R O Williams
Jul 21, 1998·Antisense & Nucleic Acid Drug Development·M F TaylorL Kobzik
Nov 24, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·J M Argilés, F J López-Soriano
Sep 14, 2002·Annals of the Rheumatic Diseases·M J LeandroG Cambridge
Jul 15, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L Rifas, L V Avioli
Dec 30, 1998·Calcified Tissue International·L Rifas
Jan 5, 2002·Journal of Neuroimmunology·Premkumar Christadoss, Elzbieta Goluszko
Jan 3, 2012·Wiener klinische Wochenschrift·Antonia PuchnerKurt Redlich
Jun 28, 2011·Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association·Lawrence V GulottaScott A Rodeo
Jun 13, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mohammed F ShamjiLori A Setton
Aug 9, 2003·Arthritis and Rheumatism·Geraldine CambridgeAnthony D B Webster
Sep 19, 2006·Best Practice & Research. Clinical Rheumatology·J C W EdwardsM J Leandro
Apr 24, 2007·Osteoarthritis and Cartilage·A HennerbichlerF Guilak
Jan 4, 2005·European Journal of Pharmacology·Yoshihiro WadaShigeru Ushiyama
Oct 18, 2000·Rheumatology·E ZanelliR R de Vries
Nov 5, 2015·Orthopaedic Journal of Sports Medicine·Mary K MulcaheyTheodore A Blaine
Jun 7, 2005·International Immunology·Jiaxiang JiMiles W Cloyd
Dec 4, 1998·Springer Seminars in Immunopathology·M FeldmannR N Maini
Oct 31, 2012·Radiation Research·Dörthe SchaueWilliam H McBride
Apr 17, 2004·Experimental Dermatology·Arndt J G SchotteliusCarl K Edwards
Aug 12, 2003·Expert Review of Vaccines·Matthias G von Herrath
May 16, 2002·Current Rheumatology Reports·Margriet J B M Vervoordeldonk, Paul P Tak
Dec 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Timothy A SatoMurray D Mitchell
Oct 13, 2020·Critical Reviews in Biotechnology·Muhammad Safwan AkramAli K Yetisen
Jan 13, 2005·Scandinavian Journal of Immunology·U SackJ Lehmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here